Literature DB >> 11501342

Interaction between apolipoprotein-E and angiotensin-converting enzyme genotype in Alzheimer's disease.

T Isbir1, B Agaçhan, H Yilmaz, M Aydin, I Kara, D Eker, E Eker.   

Abstract

Both apolipoprotein-E (apo-E) epsilon 4 allele and angiotensin-converting enzyme (ACE) deletion (D) polymorphism have been associated with a high risk for coronary heart disease. Increased frequency of the epsilon 4 allele has also been reported in patients with late-onset of familial and sporadic Alzheimer's disease (AD). The primary aim of this study is to examine the possible relationship between the ACE gene polymorphism and AD. The second aim of this study is to explore the relation of the ACE and apo-E genotypes with AD. Polymerase chain reaction (PCR), restriction fragment length polymorphism (RFLP), and agarose gel electrophoresis techniques were used to determine the apo-E and ACE genotypes. The frequencies of ACE D and ACE insertion (I) allele among AD patients and controls were 55.7 percent versus 44.2 percent and 51.7 versus 48.2 percent, respectively. Apo-E allele frequencies in the AD group for epsilon 2, epsilon 3 and epsilon 4 were, 1.7 percent, 96.5 percent, and 1.7 percent, respectively. The apo-E allele frequencies of healthy groups for epsilon 2, epsilon 3 and epsilon 4 were 1 percent, 56 percent, and 1.7 percent, respectively. In conclusion ACE D and apo epsilon 4 allele were found to be more frequent in patients with Alzheimer's disease than in the control group.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11501342     DOI: 10.1177/153331750101600407

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  7 in total

1.  The insertion polymorphism in angiotensin-converting enzyme gene associated with the APOE epsilon 4 allele increases the risk of late-onset Alzheimer disease.

Authors:  Binbin Wang; Feng Jin; Ze Yang; Zeping Lu; Rui Kan; Shu Li; Chenguang Zheng; Li Wang
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  Angiotensin-converting enzyme gene insertion-deletion polymorphism is a risk marker for Alzheimer's disease in a Chinese population: a meta-analysis of case-control studies.

Authors:  Ye Yuan; Jin-hua Piao; Ke Ma; Na Lu
Journal:  J Neural Transm (Vienna)       Date:  2015-01-18       Impact factor: 3.575

3.  Angiotensin-converting enzyme insertion/deletion polymorphism is not a major determining factor in the development of sporadic Alzheimer disease: evidence from an updated meta-analysis.

Authors:  Xue-bin Wang; Ning-hua Cui; Jie Yang; Xue-ping Qiu; Jia-jia Gao; Na Yang; Fang Zheng
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

4.  Association between an angiotensin-converting enzyme gene polymorphism and Alzheimer's disease in a Tunisian population.

Authors:  Najiba Fekih-Mrissa; Ines Bedoui; Aycha Sayeh; Hajer Derbali; Meriem Mrad; Ridha Mrissa; Brahim Nsiri
Journal:  Ann Gen Psychiatry       Date:  2017-11-17       Impact factor: 3.455

5.  Levels of Angiotensin-Converting Enzyme and Apolipoproteins Are Associated with Alzheimer's Disease and Cardiovascular Diseases.

Authors:  Chun Xu; Debra Garcia; Yongke Lu; Kaysie Ozuna; Donald A Adjeroh; Kesheng Wang
Journal:  Cells       Date:  2021-12-23       Impact factor: 6.600

6.  Angiotensin-converting enzyme polymorphisms AND Alzheimer's disease susceptibility: An updated meta-analysis.

Authors:  Xiao-Yu Xin; Ze-Hua Lai; Kai-Qi Ding; Li-Li Zeng; Jian-Fang Ma
Journal:  PLoS One       Date:  2021-11-24       Impact factor: 3.240

Review 7.  Disruption of the circadian timing systems: molecular mechanisms in mood disorders.

Authors:  Julien Mendlewicz
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.